The Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma
Open accessThe DOI matches its Crossref record; 116 of the 119 references it cites were found in a registry or an index.
Abstract
Cancer stem cells (CSCs) are the main culprits involved in therapy resistance and disease recurrence in colorectal carcinoma (CRC). Results using cell culture, animal models and tissues from patients with CRC suggest the indispensable roles of colorectal CSCs in therapeutic failure. Conventional therapies target proliferating and mature cancer cells, while CSCs are mostly quiescent and poorly differentiated, thereby they can easily survive chemotherapeutic insults. The aberrant activation of Wnt/β-catenin, Notch, Hedgehog, Hippo/YAP (Yes-associated protein) and phosphatidylinositol 3-kinase/protein kinase B facilitates CSCs with excessive self-renewal and therapy resistance property in CRC. CSCs survive the chemo-radiotherapies by escaping therapy mediated DNA damage via altering the cell cycle checkpoints, increasing DNA damage repair capacity and by an efficient scavenging of reactive oxygen species. Furthermore, dysregulations of miRNAs e.g., miR-21, miR-93, miR-203, miR-215, miR-497 etc., modulate the therapeutic sensitivity of colorectal CSCs by regulating growth and survival signalling. In addition, a reversible quiescent G0 state and the re-entering cell cycle capacity of colorectal CSCs can accelerate tumour regeneration after treatment. Moreover, switching to favourable metabolic signatures during a therapeutic regimen will add more complexity in therapeutic outcomes against CSCs. Therapeutic strategies targeting these underlying mechanisms of CSCs’ therapy resistance could provide a promising outcome, however, deep understanding and concerted research are necessary to design novel therapies targeting CSCs. To conclude, the understanding of these mechanisms of CSC in CRC could lead to the improved management of patients with CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“While conventional therapies target rapidly proliferating and more differentiated cancer cells, CSCs are slow-growing or quiescent and poorly differentiated [70].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [70]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, CSCs can adapt in response to chemotherapy and radiotherapy by altering cell cycle checkpoints, by inducing cell cycle arrest (reversible quiescent G0 state), or by efficient scavenging of ROS [70].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [70]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Loss of Hmga1 gene function affects embryonic stem cell lymphohematopoietic differentiation
Battista, S., Pentimalli, F., Baldassarre, G., Fedele, M., Fidanza, V., Croce, C. M., & Fusco, A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0977fje · Cited by 69
RetractedMultidrug resistance in cancer: role of ATP–dependent transporters
Gottesman, M. M., Fojo, T., & Bates, S. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc706 · Cited by 5,536
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681 · cited 1×
“For example, mutations in key signalling pathway molecules, the increased expression of anti-apoptotic proteins, the presence of quiescent and/or resistant tumour cells or the over-activation of drug efflux pumps are all potential causes of therapy failure [4,5].”
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555
Park, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272 · cited 2×
“These differential expressed miRNAs, such as miR-451, miR-429 and miR-155, are associated with the differentiation and EMT process in CSCs [65,66].”
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,342
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4
Todaro, M., Alea, M. P., Di Stefano, A. B., Cammareri, P., Vermeulen, L., Iovino, F., Tripodo, C., Russo, A., Gulotta, G., Medema, J. P., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.001 · Cited by 1,039
ABC transporters in cancer: more than just drug efflux pumps
Fletcher, J. I., Haber, M., Henderson, M. J., & Norris, M. D. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2789 · Cited by 1,018
Exploring the role of cancer stem cells in radioresistance
Baumann, M., Krause, M., & Hill, R. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2419 · Cited by 815
Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
LoPiccolo, J., Blumenthal, G. M., Bernstein, W. B., & Dennis, P. A. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2007.11.003 · Cited by 801
Kong, W., Yang, H., He, L., Zhao, J.-J., Coppola, D., Dalton, W. S., & Cheng, J. Q. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00941-08 · Cited by 689
Biological response of cancer cells to radiation treatment
Baskar, R., Dai, J., Wenlong, N., Yeo, R., & Yeoh, K.-W. (2014) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2014.00024 · Cited by 638
Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
Dylla, S. J., Beviglia, L., Park, I.-K., Chartier, C., Raval, J., Ngan, L., Pickell, K., Aguilar, J., Lazetic, S., Smith-Berdan, S., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002428 · Cited by 589
Dow, L. E., O’Rourke, K. P., Simon, J., Tschaharganeh, D. F., van Es, J. H., Clevers, H., & Lowe, S. W. (2015) · Cell · doi:10.1016/j.cell.2015.05.033 · Cited by 552
The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
Munz, M., Baeuerle, P. A., & Gires, O. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0654 · Cited by 515
Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
Thorne, C. A., Hanson, A. J., Schneider, J., Tahinci, E., Orton, D., Cselenyi, C. S., Jernigan, K. K., Meyers, K. C., Hang, B. I., Waterson, A. G., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.453 · Cited by 485
Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells
ten Berge, D., Kurek, D., Blauwkamp, T., Koole, W., Maas, A., Eroglu, E., Siu, R. K., & Nusse, R. (2011) · Nature Cell Biology · doi:10.1038/ncb2314 · Cited by 468
Iliopoulos, D., Hirsch, H. A., & Struhl, K. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3471 · Cited by 450
Hirsch, H. A., Iliopoulos, D., & Struhl, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221055110 · Cited by 440
Expression of CD44 in Apc and TcfMutant Mice Implies Regulation by the WNT Pathway
Wielenga, V. J. M., Smits, R., Korinek, V., Smit, L., Kielman, M., Fodde, R., Clevers, H., & Pals, S. T. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65297-2 · Cited by 433
Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells
Song, B., Wang, Y., Xi, Y., Kudo, K., Bruheim, S., Botchkina, G. I., Gavin, E., Wan, Y., Formentini, A., Kornmann, M., et al. (2009) · Oncogene · doi:10.1038/onc.2009.274 · Cited by 410
A role for cancer stem cells in therapy resistance: Cellular and molecular mechanisms
Cojoc, M., Mäbert, K., Muders, M. H., & Dubrovska, A. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.06.004 · Cited by 393
Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer
Rodilla, V., Villanueva, A., Obrador-Hevia, A., Robert-Moreno, À., Fernández-Majada, V., Grilli, A., López-Bigas, N., Bellora, N., Albà, M. M., Torres, F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813221106 · Cited by 384
A microRNA miR-34a-Regulated Bimodal Switch Targets Notch in Colon Cancer Stem Cells
Bu, P., Chen, K.-Y., Chen, J. H., Wang, L., Walters, J., Shin, Y. J., Goerger, J. P., Sun, J., Witherspoon, M., Rakhilin, N., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.03.002 · Cited by 357
Differentiation therapy of leukemia: 3 decades of development.
Nowak, D., Stewart, D., & Koeffler, H. P. (2009) · Blood · doi:10.1182/blood-2009-01-198911 · Cited by 348
Wang, Z., Li, Y., Ahmad, A., Azmi, A. S., Kong, D., Banerjee, S., & Sarkar, F. H. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.07.001 · Cited by 343
Touil, Y., Igoudjil, W., Corvaisier, M., Dessein, A.-F., Vandomme, J., Monté, D., Stechly, L., Skrypek, N., Langlois, C., Grard, G., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1854 · Cited by 332
Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy
Ciardiello, D., Vitiello, P. P., Cardone, C., Martini, G., Troiani, T., Martinelli, E., & Ciardiello, F. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.04.003 · Cited by 304
Kim, M. P., Fleming, J. B., Wang, H., Abbruzzese, J. L., Choi, W., Kopetz, S., McConkey, D. J., Evans, D. B., & Gallick, G. E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020636 · Cited by 290
Meng, R. D., Shelton, C. C., Li, Y.-M., Qin, L.-X., Notterman, D., Paty, P. B., & Schwartz, G. K. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2088 · Cited by 287
Bitarte, N., Bandres, E., Boni, V., Zarate, R., Rodriguez, J., Gonzalez-Huarriz, M., Lopez, I., Javier Sola, J., Alonso, M. M., Fortes, P., et al. (2011) · Stem Cells · doi:10.1002/stem.741 · Cited by 272
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells
Song, B., Wang, Y., Titmus, M. A., Botchkina, G., Formentini, A., Kornmann, M., & Ju, J. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-96 · Cited by 265
Yu, Y., Kanwar, S. S., Patel, B. B., Oh, P.-S., Nautiyal, J., Sarkar, F. H., & Majumdar, A. P. N. (2012) · Carcinogenesis · doi:10.1093/carcin/bgr246 · Cited by 258
Cancer stem cells and radioresistance
Rycaj, K., & Tang, D. G. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.892227 · Cited by 254
ATM, a central controller of cellular responses to DNA damage
Khanna, K., Lavin, M., Jackson, S., & Mulhern, T. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400874 · Cited by 252
Cancer stem cells – important players in tumor therapy resistance
Colak, S., & Medema, J. P. (2014) · The FEBS Journal · doi:10.1111/febs.13023 · Cited by 248
Lombardo, Y., Scopelliti, A., Cammareri, P., Todaro, M., Iovino, F., Ricci–Vitiani, L., Gulotta, G., Dieli, F., de Maria, R., & Stassi, G. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.005 · Cited by 222 · cited 2×
“A growing body of evidence suggests that CSCs in CRC exhibit intrinsic characteristics of therapy resistance and are associated with cancer regeneration and recurrence after conventional therapies [9,10,13,14].”
Guo, S. T., Jiang, C. C., Wang, G. P., Li, Y. P., Wang, C. Y., Guo, X. Y., Yang, R. H., Feng, Y., Wang, F. H., Tseng, H.-Y., et al. (2013) · Oncogene · doi:10.1038/onc.2012.214 · Cited by 218
Vellinga, T. T., Borovski, T., de Boer, V. C. J., Fatrai, S., van Schelven, S., Trumpi, K., Verheem, A., Snoeren, N., Emmink, B. L., Koster, J., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2290 · Cited by 203
Hu, Y.-B., Yan, C., Mu, L., Mi, Y. –., Zhao, H., Hu, H., Li, X.-L., Tao, D.-D., Wu, Y.-Q., Gong, J.-P., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0557-9 · Cited by 200
Borralho, P. M., Kren, B. T., Castro, R. E., Moreira da Silva, I. B., Steer, C. J., & Rodrigues, C. M. P. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07383.x · Cited by 195
Discovery of the cancer stem cell related determinants of radioresistance
Peitzsch, C., Kurth, I., Kunz-Schughart, L., Baumann, M., & Dubrovska, A. (2013) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2013.06.003 · Cited by 189
Akao, Y., Noguchi, S., Iio, A., Kojima, K., Takagi, T., & Naoe, T. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.10.006 · Cited by 181
Chen, X., Sun, K., Jiao, S., Cai, N., Zhao, X., Zou, H., Xie, Y., Wang, Z., Zhong, M., & Wei, L. (2014) · Scientific Reports · doi:10.1038/srep07481 · Cited by 168
Denise, C., Paoli, P., Calvani, M., Taddei, M. L., Giannoni, E., Kopetz, S., Kazmi, S. M. A., Pia, M. M., Pettazzoni, P., Sacco, E., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5991 · Cited by 164
miR-21 and miR-145 cooperation in regulation of colon cancer stem cells
Yu, Y., Nangia-Makker, P., Farhana, L., G. Rajendra, S., Levi, E., & Majumdar, A. P. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0372-7 · Cited by 163
Zhao, M., Luo, R., Liu, Y., Gao, L., Fu, Z., Fu, Q., Luo, X., Chen, Y., Deng, X., Liang, Z., et al. (2016) · Nature Communications · doi:10.1038/ncomms11309 · Cited by 162
MicroRNAs as therapeutic targets in chemoresistance
Garofalo, M., & Croce, C. M. (2013) · Drug Resistance Updates · doi:10.1016/j.drup.2013.05.001 · Cited by 153
Targeting LGR5 in Colorectal Cancer: therapeutic gold or too plastic?
Morgan, R., Mortensson, E., & Williams, A. C. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0118-6 · Cited by 153
MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors.
Luraghi, P., Reato, G., Cipriano, E., Sassi, F., Orzan, F., Bigatto, V., De Bacco, F., Menietti, E., Han, M., Rideout, W. M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2340-t · Cited by 146
Islam, F., Gopalan, V., Smith, R. A., & Lam, A. K.-Y. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.04.018 · Cited by 145
Self-citationZhai, H., Fesler, A., Ba, Y., Wu, S., & Ju, J. (2015) · Oncotarget · doi:10.18632/oncotarget.3771 · Cited by 139
Cellular and molecular effects of sirtuins in health and disease
Horio, Y., Hayashi, T., Kuno, A., & Kunimoto, R. (2011) · Clinical Science · doi:10.1042/cs20100587 · Cited by 135
Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells
Çolak, S., Zimberlin, C., Fessler, E., Hogdal, L. J., Prasetyanti, P. R., Grandela, C., Letai, A. G., & Medema, J. P. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.37 · Cited by 129
miR-93 suppresses proliferation and colony formation of human colon cancer stem cells
Yu, X., Zou, J., 保志军, & Dong, J. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i42.4711 · Cited by 129
Role of microRNAs in maintaining cancer stem cells
Garofalo, M., & Croce, C. M. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.11.014 · Cited by 127
Suto, T., Yokobori, T., Yajima, R., Morita, H., Fujii, T., Yamaguchi, S., Altan, B., Tsutsumi, S., Asao, T., & Kuwano, H. (2015) · Carcinogenesis · doi:10.1093/carcin/bgu242 · Cited by 125
Repressor roles for TCF-4 and Sfrp1 in Wnt signaling in breast cancer
Shulewitz, M. J., Soloviev, I., Wu, T., Koeppen, H., Polakis, P. G., & Sakanaka, C. (2006) · Oncogene · doi:10.1038/sj.onc.1209470 · Cited by 124
HMGA1: A Master Regulator of Tumor Progression in Triple-Negative Breast Cancer Cells
Shah, S. N., Cope, L., Poh, W., Belton, A., Roy, S., Talbot, C. C., Sukumar, S., Huso, D. L., & Resar, L. M. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063419 · Cited by 123
Xu, X. T., Xu, Q., Tong, J. L., Zhu, M. M., Nie, F., Chen, X., Xiao, S. D., & Ran, Z. H. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.88 · Cited by 123
The CDX1–microRNA-215 axis regulates colorectal cancer stem cell differentiation
Jones, M. F., Hara, T., Francis, P., Li, X. L., Bilke, S., Zhu, Y. J., Pineda, M. A., Subramanian, M., Bodmer, W. F., & Lal, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503370112 · Cited by 106
Belton, A., Gabrovsky, A., Bae, Y. K., Reeves, R., Iacobuzio-Donahue, C., Huso, D. L., & Resar, L. M. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030034 · Cited by 104
Shang, J., Yang, F., Wang, Y., Wang, Y., Xue, G., Mei, Q., Wang, F., & Sun, S. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24721 · Cited by 103
Li, J., Zhang, Y., Zhao, J., Kong, F., & Chen, Y. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0872-8 · Cited by 102
Vázquez‐Martín, A., Vellón, L., Quirós, P. M., Cufí, S., de Galarreta, E. R., Oliveras‐Ferraros, C., Martín, Á. G., Martín-Castillo, B., López-Otín, C., & Menéndez, J. A. (2012) · Cell Cycle · doi:10.4161/cc.11.5.19450 · Cited by 100
Usui, T., Sakurai, M., Umata, K., Elbadawy, M., Ohama, T., Yamawaki, H., Hazama, S., Takenouchi, H., Nakajima, M., Tsunedomi, R., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041098 · Cited by 96
Wan, L., Deng, J., Xiang, X., Zhang, L., Yu, F., Chen, J., Sun, Z., Miao, F., & Xiong, J. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.11.039 · Cited by 95
He, J., Xie, G., Tong, J., Peng, Y., Haihui, H., Li, J., Wang, N., & Liang, H. (2014) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-014-0062-x · Cited by 95
Ju, S.-Y., Chiou, S.-H., & Su, Y. (2014) · Stem Cell Research · doi:10.1016/j.scr.2013.09.011 · Cited by 92
Underexpression of miR-224 in methotrexate resistant human colon cancer cells
Mencia-Trinchant, N., Selga, E., Noé, V., & Ciudad, C. J. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.009 · Cited by 90
Francescangeli, F., Contavalli, P., De Angelis, M. L., Careccia, S., Signore, M., Haas, T. L., Salaris, F., Baiocchi, M., Boe, A., Giuliani, A., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1505-4 · Cited by 88
LI, X., ZHAO, H., ZHOU, X., & SONG, L. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2726 · Cited by 86
The Hippo pathway in colorectal cancer
Wierzbicki, P., & Rybarczyk, A. (2015) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2015.0015 · Cited by 86
Qu, J., Zhao, L., Zhang, P., Wang, J., Xu, N., Mi, W., Jiang, X., Zhang, C., & Qu, J. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24366 · Cited by 84
EGF signalling pathway regulates colon cancer stem cell proliferation and apoptosis
Feng, Y., Dai, X., Li, X., Wang, H., Liu, J., Zhang, J., Du, Y., & Xia, L. (2012) · Cell Proliferation · doi:10.1111/j.1365-2184.2012.00837.x · Cited by 83
MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line
Zhang, H., Li, W., Nan, F., Ren, F., Wang, H., Xu, Y., & Zhang, F. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.106 · Cited by 83
Plasticity of Cancer Stem Cell: Origin and Role in Disease Progression and Therapy Resistance
Das, P. K., Pillai, S., Rakib, M. A., Khanam, J. A., Gopalan, V., Lam, A. K.-Y., & Islam, F. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-019-09942-y · Cited by 81
Self-citationHypoxia- and MicroRNA-Induced Metabolic Reprogramming of Tumor-Initiating Cells
Ullmann, P., Nurmik, M., Begaj, R., Haan, S., & Letellier, E. (2019) · Cells · doi:10.3390/cells8060528 · Cited by 77
Aberrant GLI1 Activation in DNA Damage Response, Carcinogenesis and Chemoresistance
Palle, K., Mani, C., Tripathi, K. K., & Athar, M. (2015) · Cancers · doi:10.3390/cancers7040894 · Cited by 77
Comparative genomics on PROM1 gene encoding stem cell marker CD133
Katoh, Y., & Katoh, M. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.6.967 · Cited by 77
Bogachek, M. V., Park, J. M., De Andrade, J. P., Lorenzen, A. W., Kulak, M. V., White, J. R., Gu, V. W., Wu, V. T., & Weigel, R. J. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.11.001 · Cited by 73
Fang, Y., Gu, X., Li, Z., Xiang, J., & Chen, Z. (2013) · Oncology Reports · doi:10.3892/or.2013.2465 · Cited by 67
Puca, F., Colamaio, M., Federico, A., Gemei, M., Tosti, N., Bastos, A. U., Vecchio, L. D., Pece, S., Battista, S., & Fusco, A. (2014) · Oncotarget · doi:10.18632/oncotarget.1914 · Cited by 65
Clinicopathological significance of SIRT1 expression in colorectal adenocarcinoma
Lv, L., Shen, Z., Zhang, J., Zhang, H., Dong, J., Yan, Y., Liu, F., Jiang, K., Ye, Y., & Wang, S. (2014) · Medical Oncology · doi:10.1007/s12032-014-0965-9 · Cited by 65
Chen, B., Zhang, D., Kuai, J., Cheng, M., Fang, X., & Li, G. (2017) · Tumor Biology · doi:10.1177/1010428317715155 · Cited by 63
HUANG, R., WANG, G., SONG, Y., TANG, Q., YOU, Q., LIU, Z., CHEN, Y., ZHANG, Q., LI, J., MUHAMMAND, S., et al. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3694 · Cited by 61
CHUNG, S. S., Oliva, B., Dwabe, S., & Vadgama, J. V. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3546 · Cited by 61
Zhang, J., He, P., Xi, Y., Geng, M., Chen, Y., & Ding, J. (2015) · Oncotarget · doi:10.18632/oncotarget.2784 · Cited by 58
Yang, Z., Cui, Y. R., Ni, W., Kim, S., & Xuan, Y. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2273-6 · Cited by 58
γH2AX Assay as DNA Damage Biomarker for Human Population Studies: Defining Experimental Conditions
Sánchez-Flores, M., Pásaro, E., Bonassi, S., Laffon, B., & Valdiglesias, V. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv011 · Cited by 56
Solier, S., Zhang, Y., Ballestrero, A., Pommier, Y. G., & Zoppoli, G. M. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912800190901 · Cited by 56
Pan, M.-R., Hsu, M.-C., Luo, C.-W., Chen, L.-T., Shan, Y.-S., & Hung, W.-C. (2016) · Oncotarget · doi:10.18632/oncotarget.11256 · Cited by 56
Tolba, M. F., & Abdel-Rahman, S. Z. (2015) · Scientific Reports · doi:10.1038/srep15239 · Cited by 55
NECTIN-4 increased the 5-FU resistance in colon cancer cells by inducing the PI3K–AKT cascade
Das, D., Satapathy, S. R., Siddharth, S., Nayak, A., & Kundu, C. N. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2794-8 · Cited by 55
Wang, J., Wang, W., Cai, H., Du, B., Zhang, L., Ma, W., Hu, Y., Feng, S., & Miao, G. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7721 · Cited by 55
Fu, Q., Du, Y., Yang, C., Zhang, D., Zhang, N., Liu, X., Cho, W. C. S., & Yang, Y. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1181753 · Cited by 55
Functional significance of Hippo/YAP signaling for drug resistance in colorectal cancer
Song, R., Gu, D., Zhang, L., Zhang, X., Yu, B., Liu, B., & Xie, J. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22883 · Cited by 51
Therapeutic strategies against cancer stem cells in human colorectal cancer (Review)
Szaryńska, M., Olejniczak-Kęder, A., Kobiela, J., Spychalski, P., & Kmieć, Z. (2017) · Oncology Letters · doi:10.3892/ol.2017.7261 · Cited by 49
Symmetric Division Versus Asymmetric Division: A Tale of Two Coactivators
Kahn, M. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.126 · Cited by 49
Zu, G., Ji, A., Zhou, T., & Che, N. (2016) · International Journal of Surgery · doi:10.1016/j.ijsu.2016.01.002 · Cited by 49
Radiation-induced DNA damage response and resistance in colorectal cancer stem-like cells
Anuja, K., Chowdhury, A. R., Saha, A., Roy, S., Rath, A. K., Kar, M., & Banerjee, B. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1580401 · Cited by 48
Fang, D. D., Zhang, C. C., Gu, Y., Jani, J. P., Cao, J., Tsaparikos, K., Yuan, J., Thiel, M., Jackson-Fisher, A., Zong, Q., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067258 · Cited by 44
Luo, C., Wang, J., Hung, W.-C., Peng, G., Tsai, Y.-L., Chang, T., Chai, C., Lin, C., & Pan, M. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.03.002 · Cited by 43
G9a orchestrates PCL3 and KDM7A to promote histone H3K27 methylation
Pan, M., Hsu, M., Chen, L., & Hung, W. (2015) · Scientific Reports · doi:10.1038/srep18709 · Cited by 42
Correction: Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy
Dylla, S. J., Beviglia, L., Park, I.-K., Chartier, C., Raval, J., Ngan, L., Pickell, K., Aguilar, J., Lazetic, S., Smith‐Berdan, S., et al. (2008) · PLoS ONE · doi:10.1371/annotation/2aa6a20a-e63c-49b6-aeea-aae62435617f · Cited by 42
Martino‐Echarri, E., Henderson, B. R., & Brocardo, M. G. (2014) · Oncotarget · doi:10.18632/oncotarget.2475 · Cited by 41
Agarwal, P., & Jackson, S. P. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.07.009 · Cited by 40
Ayadi, M., Bouygues, A., Ouaret, D., Ferrand, N., Chouaïb, S., Thiery, J. P., Muchardt, C., Sabbah, M., & Larsen, A. K. (2015) · Oncotarget · doi:10.18632/oncotarget.3934 · Cited by 38
The CDK inhibitors: potential targets for therapeutic stem cell manipulations?
Boyer, M. J., & Cheng, T. (2007) · Gene Therapy · doi:10.1038/sj.gt.3303064 · Cited by 36
MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer
Liu, X., Fu, Q., Du, Y., Yang, Y., & Cho, W. C. S. (2016) · Current Cancer Drug Targets · doi:10.2174/1568009616666151118114759 · Cited by 33
Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy
Das, P. K., Zahan, T., Rakib, M. A., Khanam, J. A., Pillai, S., & Islam, F. (2019) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520619666190704111714 · Cited by 32
Self-citationHuynh, N., Shulkes, A., Baldwin, G., & He, H. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1195045 · Cited by 32
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Lonardo, E., Cioffi, M., Sancho, P., Crusz, S. M., & Heeschen, C. (2015) · Journal of Visualized Experiments · doi:10.3791/52801 · Cited by 31
Fang, Y., Xiang, J., Chen, Z., Gu, X., Li, Z., Tang, F., & Zhou, Z. (2012) · Oncology Reports · doi:10.3892/or.2012.2054 · Cited by 29
Kim, E.-J., Davidson, L. A., Zoh, R. S., Hensel, M. E., Patil, B. S., Jayaprakasha, G. K., Callaway, E. S., Allred, C. D., Turner, N. D., Weeks, B. R., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv250 · Cited by 24
Radiotherapy Enhancement with Electroporation in Human Intestinal Colon Cancer HT-29 Cells
Yadollahpour, A., Rezaee, Z., Bayati, V., Birgani, M. J. T., & Dehbashi, F. N. (2018) · PubMed Central · doi:10.22034/apjcp.2018.19.5.1259 · Cited by 17
Cited by
Sethy, C., & Kundu, C. N. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111285 · Cited by 539
Colorectal liver metastasis: molecular mechanism and interventional therapy
Zhou, H., Liu, Z., Wang, Y., Wen, X., Amador, E. H., Yuan, L., Ran, X., Xiong, L., Ran, Y., Chen, W., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00922-2 · Cited by 298
Azwar, S., Seow, H. F., Abdullah, M., Faisal Jabar, M., & Mohtarrudin, N. (2021) · Biology · doi:10.3390/biology10090854 · Cited by 173
Miao, Z., Zhao, X., & Liu, X. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113439 · Cited by 138
Far, B. F., Vakili, K. G., Fathi, M., Yaghoobpoor, S., Bhia, M., & Naimi‐Jamal, M. R. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121340 · Cited by 121
Metadata
- Authors
- Das, P. K., Islam, F., & Lam, A. K.
- Affiliations
- University of Rajshahi (BD)
- Griffith University (AU)
- Corresponding author
- Islam, Farhadul
- Lam, Alfred K.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-06-03
- Volume
- 9
- Issue
- 6
- Pages
- 1392
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7348976
- OpenAlex
- W3033624893
- Cited by
- 210
- References
- 119
- Citations by year
- 2026: 12 · 2025: 29 · 2024: 42 · 2023: 47 · 2022: 48 · 2021: 27 · 2020: 5
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Griffith Research Online (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- cancer stem cells, colorectal cancer, treatment resistance, Wnt/β-catenin signaling, Notch signaling, Hedgehog signaling, Hippo/YAP signaling, PI3K/Akt signaling, DNA repair, reactive oxygen species scavenging, cell cycle checkpoints, microRNA, metabolic reprogramming, chemoradiotherapy, self-renewal
- MeSH terms
- Animals, DNA Damage, Humans, Neoplastic Stem Cells, Colorectal Neoplasms, Signal Transduction, Drug Resistance, Neoplasm, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.